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Immunoglobulin-A distribution in glomerular disease. Analysis
of immunofluorescence localization and pathogenetic significance.
Renal biopsies from 470 patients with various glomerulonephro-
pathies were studied for patterns and frequency of glomerular
bound IgA. Correlations of IgA with lgG, 1gM, C3, and C4
were made. Glomerular deposits of IgA were observed in five of
six cases of Henoch-Schoenlein anaphylactoid nephritis (83%),
stalk proliferative glomerulonephritis (73%), lupus nephritis
(60%), and focal proliferative glomerulonephritis (57%). In addi-
tion, IgA was less frequently observed in diffuse (acute) prolif-
erative (33%), membranoproliferative (42%), membranous
(32%), focal scierosing (25%) crescentic (26%), and chronic
glomerulonephritides (23 %) as well as malignant arterionephro-
sclerosis, amyloidosis, and a group of patients with minimal
glomerular alteration and no determinable diagnosis (40%).
IgA was not specifically associated with IgG or 1gM in any one
diagnostic category but was often present with both. Deposits
containing C3 and C4 most closely paralleled those of I gG and/or
1gM. Presence of IgA appeared to correlate with variable degrees
of increased glomerular mesangial cellularity in "minimal,"
stalk proliferative, and focal-segmental glomerular lesions. The
cause and immunopathogenetic significance of mesangial or
peripheral glomerular capillary localization of IgA is unknown.
Though a number of apparent examples of what has been referred
to as IgA-IgG nephropathy were observed in this study, this
entity, characterized by mesangial deposits of IgA, IgG, and C3,
could not always be specifically identified or differentiated on
histopathologic criteria alone from a variety of other glomerulo-
pathies in which variable proportions of IgA, IgG, 1gM, C3,
and C4 globulins were localized.
Distribution de l'immunoglobuline-A dans les affections glomé-
rulaires: Analyse de la localisation par immunofluorescence et de
Ia signification pathogénique. Les biopsies rénales de 470 malades
atteints de néphropathies glomérulaires diverses ont été étudiées
du point de vue des aspects et de Ia frequence des dépôts glomé-
rulaires d'IgA. Les correlations de l'IgA avec l'IgG, l'IgM, C3
et C4 ont été recherchées. Les depots glomérulaires d'IgA ont
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été observes dans 5 cas sur 6 de néphropathie anaphylactoide
de Henoch-Schoenlein (83%), dans les proliférations mésangiales
(73%), dans 60% des néphropathies lupiques et 57% des
glomérulonéphrites focales prolifératives. L'IgA a été moms
fréquemment observée dans les glomérulonéphrites prolifératives
diffuses (33%), membranoprolifératives (42%), membraneuses
(32%), sclérosantes focales (25 %), avec croissants (26%) et les
néphropathies glomerulaires chroniques (23%) de méme qu'au
cours de l'artério-néphro-sclérose, de l'amyloidose et dans un
groupe de malades qui avaient des alterations glomerulaires
minimes sans diagnostic défini (40%). L'IgA n'était pas spéci-
fiquement associée a l'IgG ou a l'IgM dans l'une de ces categories
de diagnostics mais était souvent présente en méme temps que
l'IgG et l'IgM. Les dépôts contenant C3 et C4 étaient les plus
étroitements corrélés a ceux d'IgG et/ou 1gM. La presence d'IgA
est apparue être en correlation avec les divers degrés d'aug-
mentation de Ia cellularité mesangiale dans les lesions gloméru-
laires minimes, les proliférations mésangiales et les lesions
segmentaires focales. La cause et la signification immunopatho-
génique des localisations de 1'IgA dans le mésangium ou a Ia
périphéric des capillaires glomerulaires est inconnue. Bien que
de nombreux exemples apparents de ce qui a été décrit sous le
nom de néphropathie a IgA-IgG aient été observes dans cette
étude, cette entité — caractérisée par des dépôts mésangiaux
d'IgA, d'IgG et de C3 — n'a pas toujours Pu être identifiée
spécifiquement ou différenciée en fonction des seuls critères
histopathologiques de diverses autres néphropathies glomeru-
laires dans lesquelles des proportions variables d'IgA, d'IgM
de C3 et de C4 ont été localisées.
Fluorescent antibody reagent reactive with human im-
munoglobulin-A (IgA) is often used in conjunction with a
battery of fluorescent antibody reagents monospecifically
reactive with other serum proteins in evaluation of renal
biopsies, but diagnostic and pathologic significance of the
presence of IgA in kidney disease has not been clearly
established. Recent reports indicate that IgA is frequently
detected in selected pathologic entities such as the nephritis
of Henoch-Schoenlein anaphylactoid purpura, lupus gb-
merulonephritis and in some types of focal proliferative gb-
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merulonephritis [1 —9]. Furthermore, Berger has recently
described a newly recognized glomerulopathy characterized
immunohistochemically by predominantly mesangial de-
posits of IgA, IgG, and C3 in the setting of mild stalk or
focal segmental proliferative glomerular lesions [3].
This report constitutes a detailed description of the
incidence, patterns, and distribution of glomerular bound
IgA and other associated immunoglobulins and C3 in
470 renal biopsies from patients with clinicopathologically
defined glomerular diseases.
Methods
Immunofluorescence microscopic evaluation for the pres-
ence and distribution of glomerular localization of IgA was
performed on 470 of over 1,500 renal biopsies from Duke
University Medical Center, the University of Wisconsin
Medical Center, and the Veterans Administration Hospital,
Madison, Wisconsin. Diagnoses were established on the
basis of a combination of clinical data and histopatho logic
findings on examination of renal biopsies by light, im-
munofluorescence, and electron microscopy. The general
categories of renal diseases evaluated are listed in Table 2,
and in instances where some confusion may arise regarding
given diagnostic labels, are further defined in the Results
section.
Morphologic terminology. There is considerable confusion
created by the lack of standard descriptive terms for con-
veying impressions about the distribution and extent of
renal glomerular lesions and immunohistochemically iden-
tified deposits. In an effort to clarify this problem, Table 1
provides a glossary of descriptive terminology used in this
paper for presentation and discussion of glomerular lesions
and distribution, patterns, and localization of glomerular
bound plasma proteins.
Light microscopy. Portions of renal biopsy specimens
were fixed in buffered 10% formalin, embedded in paraffin,
and sectioned at 2 to 3 t. The sections were stained routinely
with hematoxylin and eosin and periodic acid Schiff reac-
tion. Sections from most cases were also stained with
periodic acid-methenamine silver-Masson stain and others
were stained with either periodic acid-alcian blue, or
Masson stains.
Immunofluorescence microscopy. Another portion of
the renal biopsy specimens was immediately frozen in a
matrix of 7.5% aqueous gelatin [14] or mouse liver and
stored at —70° C until sectioned at 4 p and stained. Prior
to staining with fluorescein-labeled antibody reagents,
sections were "fixed" in acetone or alcohol for 5 mm and
washed twice in phosphate buffered saline, pH 7.3. A drop
of respective fluorescent reagent was placed on the sections
which were then incubated at room temperature for 30 mm
followed by two 15 mm rinses in buffered saline. Sections
were mounted with buffered 10% glycerol and examined
and photographed with a Zeiss or Leitz fluorescence
microscope.
Terminology Definition
Localization of deposits in
glomeruli:
Mesangial
Peripheral Along the glomerular capillary
walls
Capsular In Bowman's capsule
Distribution of a lesion or
deposits in glomeruli:
Segmental
Diffuse Entirety of individual glomerular
tufts
Focal Some glomeruli in the total spec-
imen
Generalized All glomeruli in the total specimen
Complete absence of fluorescence
Mild amount, often widely inter-
spersed and of weak intensity
Moderate amount of fluorescence
Heavy, bright, maximum fluores-
cence intensity
Immunofluorescence reagents and control evaluations.
Immune sera monospecifically reactive with selected
components of human sera were purchased from a variety
of commercial sources (Hyland, Behring-Werke, Cappel
Laboratories, Kallestadt, and Miles Laboratories) or were
prepared in our laboratories. After immunoelectrophoretic
analysis and verification of monospecificity of reaction, the
immunoglobulin fractions of the various immune sera were
conjugated with fluorescein isothiocyanate [15], freed of
free fluorescein by passage through a Sephadex G-25
column, and then depleted of nonspecific fluorescent
reactants by absorption with beef liver powder. The major
immunofluorescent reagents used in this study were im-
munoglobulins reactive with heavy chain moieties of human
IgA, IgG, and 1gM, and with human C3 and fibrinogen.
Table 1. Glossary of descriptive morphology for immunohisto-
chemically identified deposits
Within stalk areas of the glomeru-
lar tuft
Portions of individual glomerular
tufts
Beaded or "lump-bumpy" fluores-
cence varying from fine granular
to coarse globular
Delicate and continuous fluores-
cence along contours of capillary
walls
Occasionally fluorescence may in-
volve interrupted, short streaks in
segments of capillary walls
Pattern of deposits in
glomeruli:
Granular
Linear
Interrupted, linear
segments
Quantitation of intensity
and/or extent of distribution
of immunofluorescence:
Negative
1+
2+
3+
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In later phases of this study an immunoglobulin reactive
with human C4 was also used.
The specificity of immunohistochemical reactivity of the
various fluorescent conjugates was verified in several ways
in many but not all cases and phases of this study. In those
instances where labeled antibodies were absorded with
respectively specific immunoglobulin, complement compo-
nent, or fibrinogen, subsequent immunofluorescent reaction
with tissues was abolished. Alternatively, in those few
instances where sections of kidney were first treated with
unlabeled antibodies, subsequent immunofluorescence reac-
tion with respective labeled antibody was markedly or
moderately inhibited. Evaluation of absence of any ap-
parent cross reactivity or possible antilight chain activity
of the antiimmunoglobulin reagents was achieved in several
ways. Though interpretations of negative agar immuno-
diffusion reactions are inconclusive, no precipitation reac-
tions were detectable between selected batches of antiheavy
chain antibodies and kappa or lambda myeloma proteins
in Ouchterlony immunodiffusion. Furthermore, in micro-
immunoelectrophoresis, only single bands of immuno-
precipitation were observed between antiheavy chain anti-
bodies and respective class of immunoglobulin, implying
that such antibodies could not react with light chains on
other classes of immunoglobulins. And finally, lack of
reaction or strikingly different patterns of reaction of one
labeled antiimmunoglobulin with glomeruli containing
deposits of one or another of the other two classes of
immunoglobulins in many cases, implies lack of cross
reactivity or light chain reactivity of each antiglobulin
conjugate.
Results
Results of this immunohistochemical investigation of the
distribution of glomerular deposits of IgA and incidence
of companion immunoglobulins in a variety of renal
diseases are summarized in Table 2. Correlative analyses
of immunoglobulin and complement component deposition
will be presented categorically for each major diagnostic
category.
Glomerulonephritis associated with systemic lupus ery-
thematosus (SLE) (Figs. 1—5). In the main this diagnosis
Table 2. Frequency of interassociation of localized immunoglobulins in diseased glomeruli
Disease
Number
of
Cases
IgA IgG
With
Alone 1gM
1gM
Alone NegativeAlone
With
IgG
With
1gM
With
lgG+IgM
Glomerulonephritides associated with
systemic lupus erythematosus
57 34 3 18 1 1
Diffuse proliferative (acute)
glomerulonephritis
40 1 2 10 6 14 1 6
Membranous glomerulopathy 28 1 8 5 14
Membranoproliferative glomerulo-
nephritis
43 1 3 14 3 15 6 1
Transplant rejection 41 1 3 4 12 10 11
Hyperacute rejection 1 1
Goodpasture's syndrome 13 3 2 8
Rapidly progressive proliferative
glomerulonephritis
22 6 5 9 1 1
Chronic glomerulonephritis 47 2 8 2 24 6 5
Stalk proliferative glomerulonephritis Ii 1 7 1 1 1
Focal proliferative glomerulonephritis 21 1 1 10 1 4 1 3
Henoch-Schoenlein purpura 6 1 4 1
Focal sclerosing glomerulo-
nephropathy with hyalinosis
24 1 5 1 10 4 3
Minimal change glomerulo-
nephropathy (" Nil disease")
22 22
Minimal glomerular alterations with
indeterminable diagnosis
58 9 2 12 6 18 11
Amyloidosis 6 3 1 1 1
Wegener's granulomatosis 4 1 1 2
Malignant arteriolonephrosclerosis 17 3
3 (art)
10 4
Diabetic glomeruloscierosis 4 2 1 1
Chronic lobular glomerulonephritis 3 1 1 1
Thrombotic thrombocytopenic purpura 1 1
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was established on the basis of standard substantiating
clinical features of SLE complicated by signs and histo-
pathologic evidence of renal involvement. Though findings
on renal biopsy occasionally were diagnostically insufficient
Figs. 1 to 5. Lupus glomerulonephritis, with diffuse peripheral
mesangial localization of :nimunoglobultns and C3 by immuno-
fluorescence microscopy. Fig. I (H & B x 200); Fig. 2 (IgA
x 180); Fig. 3 (1gM, 2 glonicruli x 180); Fig. 4 (IgG x 100);
Fig. 5 (C3 x 150).
or otherwise not typical of glomerulonephritis complicating
SLE, more often the biopsy was substantially confirmatory
and occasionally primarily responsible for the diagnosis of
SLE. We recognize that glomerular alterations in renal
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disease associated with SLE may consist of minimal
glomerular changes, variable degrees of stalk proliferative
glomerulitis, focal-segmental proliferative glomerulonephri-
tis, a variety of mixed forms of segmental and diffuse focal
proliferative glomerulonephritis, diffuse generalized prolif-
erative glomerulonephritis, crescentic proliferative gb-
merulonephritis, membranoproliferative (lobular) glome-
rulonephrit is, membranous glomerulonephropathy, and
chronic glomerubonephritis. This report does not present
the immunofluorescence data with reference to these
various histopathologic varieties of glomerular alterations,
but rather considers together all patients with SLE that
have renal involvement.
Thirty-four of 57 biopsies from patients with SLE
nephropathy (60%) had glomerular deposits of [gA.
Localization of IgA was peripheral (focal, segmental) in
12 biopsies, mesangial (generalized, diffuse) in four
biopsies, and both peripheral and mesangial (generalized,
diffuse) in 18 biopsies. In all cases, IgA fluorescence
patterns were granular and intensity was 2 to 3 +. Focal,
granular arteriolar localization of IgA was observed in
four of the glomerular IgA positive biopsies. All IgA
positive biopsies had associated IgG, 1gM, and C3 glome-
rular deposits (Figs. 2—5 and Table 2). In 23 of these
biopsies, patterns of IgU were the same as IgA (Figs, 2, 4)
and in the remaining 11, the patterns of IgG were different
than IgA. 1gM was similar to IgA in 24 biopsies and was
more variable in the other ten IgA positive biopsies.
Glomerular localization of C3 and C4 (when tested)
generally paralleled that of IgG and 1gM.
Diffuse proliferative (acute) glomerulonephritis (AGN,).
in this category are included examples of acute glomerulo-
nephritis of classical poststreptococcal type as well as those
of unproven or idiopathic etiology which clinically and
histopathologically are indistinguishable from the latter.
Among 40 biopsies of patients with AGN, 13 biopsies (33 %)
had glomerular deposits of IgA; in only three of these was
it 3 + and in the other only 1 +. Typically, igA was
localized within mesangial regions in segmental, granular
patterns. Peripheral localization (segmental, granular) was
observed in only two biopsies. Glomerular IgG was present
in all but two IgA-positive biopsies and 1gM was observed
in all but one IgA-positive biopsy. The patterns of IgG
and 1gM in these biopsies were granular, but their localiza-
tion was far more diffuse and peripheral than mesangial as
IgA. The C3 deposition paralleled that of IgG and 1gM.
Membranous glomerulonephropathy (MbGN) (Figs. 6
to JO). Nine of 28 biopsies (32%) of MbGN had granular
glomerular deposits of igA never in excess of 2+. IgA
localization was peripheral in eight biopsies (Fig. 7), focal
segmental in seven, and generalized diffuse in the other. In
the ninth biopsy IgA was observed focally and within
mesangial regions in a granular, segmental pattern. IgG
and 1gM (but for one biopsy) as well as C3 were observed
in diffuse or sometimes segmental, peripheral, granular
patterns in all IgA-positive biopsies (Figs. 8—10). Patterns
of C4, when tested, were similar to C3, IgG, and 1gM.
Membranoproliferative Glomerulonephritis (MbPGN).
Patients included in this recently fully characterized cat-
egory of glomerulonephritides [10, 11] usually have mixed
nephritic-nephrotic features, often with C3 hypocomple-
mentemia. By light microscopy, glomeruli display variable
degrees of mesangial hypercellularity and increase in
mesangial membrane matrix material, often resulting in
lobular accentuation of the tufts as well as variable, often
marked thickening of peripheral portions of gbomerular
capillary walls with regions of lamination, lacy, or tram-
track alterations.
Eighteen of 43 patients (42%) with MbPGN had
gbomerular deposits of IgA in their kidney biopsies. In
eight biopsies, IgA was localized along peripheral capillary
walls in a I to 2+ diffuse, often widely interspersed,
granular pattern. In the remaining ten biopsies IgA was
present focally, most frequently within mesangial regions
in 1 to 3 + segmental, granular or globular patterns. In
those biopsies where IgA was peripherally located, 1gM and
IgG were noted in peripheral and less impressively in
mesangial regions. In those biopsies where IgA was
localized mainly to mesangial regions, IgG and/or 1gM
were similarly located. Patterns of C4 were similar to
IgG or 1gM. C3, however, was always of impressively
greater intensity than C4, more diffusely located within
mesangial and peripheral capillary walls, and although
frequently correlating with localization of complement-
fixing immunogbobulins, was often of much greater mag-
nitude [10—11].
Renal allografts (Tx). Glomerular localization of IgA
was present in only four of 41 Tx kidneys in various stages
of rejection with or without evidence of recurrence of
gbomerular disease. In one of the four, there were rare 1+
focal, segmental, granular deposits of IgA within peripheral
capillary walls and mesangium. No 1gM or IgG was
observed in this particular case. A second kidney had 1+
focal, segmental granular IgA deposits only along peri-
pheral capillary walls with similar associated pattern of
IgG, 1gM, and C3. The remaining two kidneys had
predominantly mesangial, 2 to 3 + segmental granular
deposits of IgA along with IgG, C3, and to a lesser extent,
1gM. One renal graft with hyperacute rejection reaction
was negative for all immunoglobulins and complement
components [161.
Goodpasture's syndrome. Renal biopsies from three of
13 patients with Goodpasture's syndrome had focal rare I +
segmental granular deposits of TgA along the peripheral
glomerular capillary walls. In these biopsies there was
focal, both peripheral and mesangial, segmental granular
deposits of 1gM. All kidneys had diffuse linear igO along
gbomerular capillary walls. C3 and C4 were distributed in
a fashion similar to 1gM rather than the IgG in the igA
positive biopsies.
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Rapidly progressive proliferative glomerulonephritis
(RPGN). These patients usually have rapidly progressive
glomerular disease clinically with extracapillary crescentic
proliferation of glomerular epithelial cells. in some instances
Figs 6 to 10. Membranous glomerulonephropathy, with diffuse
peripheral glomerular localization of immunoglobulins and C3 by
immunofluorescence microscopy. Fig. 6, electron micrograph,
showing typical subepithelial-intrarnembranous electron dense
deposits (x 10,300); Fig. 7, IgA (x 180); Fig. 8, IgG (x 220);
Fig. 9, 1gM (x 180); Fig. 10, C3 (x 190).
frank necrosis of glomeruli may be observed and glomerular
membrane reactive immunoglobulins are demonstrable far
less frequently than in Goodpasture's syndrome. This
category of glomerular diseases used to be called subacute
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glomerulonephritis and is variably referred to as malignant
glomerulonephritis or extracapillary crescentic proliferative
glomeruloriephritis.
Kidney biopsies from six of 22 patients with rapidly
progressive proliferative glomerulonephritis (RPGN) had
glomerular deposits of IgA. Two of the six had 1 to 2+
diffuse fine granular, peripheral capillary deposits and the
others had segmental or diffuse granular deposits of IgA
within mesangial regions and along the peripheral capillary
walls. When associated with IgA, IgG was piesent either
in a diffuse linear pattern (two biopsies) or a diffuse fine
granular pattern (four biopsies). 1gM was present focally
in a segmental granular pattern within the mesangium in
all six IgA-positive biopsies.
Chronic glomerulonephritis (CGN). Kidney biopsies from
ten of 47 patients (23%) with CGN had focally distributed
IgA deposits. In all ten biopsies, deposition was segmental
in both peripheral and mesangial regions as globs or
clusters of granules. IgG, 1gM, and C3 were present in all
ten biopsies in variable localization and distribution with
distinctive patterns of interassociation.
Stalk proliferative glomerulonephritis (SPGN). This
category includes all those biopsies with variable but
significant degrees of increased glomerular mesangial
cellularity and matrix material without lobular accentuation
or thickening of glomerular capillary walls in patients with
nonspecific clinical features of proteinuria and mild
hematuria. This morphologic category implies no specific
disease entity and in fact undoubtedly comprises a heter-
ogeneous mixture of patients with insufficient clinical and
pathologic findings to render a satisfactory diagnosis. Early
phases of a variety of diseases that might be recognizable
later in more progressive stages, transient insignificant
forms of mild glomerulitis, resolving stages of previous
clinically unrecognized proliferative glomerulonephritis, or
insufficient quantity of biopsied tissue missing a focal
variety of glomerular disease may be conditions constituting
this category of glomerular alteration.
Kidney biopsies from eight of 11 patients (73%) with
SPGN had I to 3+ granular IgA deposits within the
mesangial regions of their glomerular tufts. Five of these
were focal and segmental, the other three were generalized
and diffuse 2 to 3 + in mesangium. IgG, 1gM, C3, and C4
(where done) were similar to IgA in seven biopsies. In one
biopsy where IgG was absent, 1gM and C3 were similar
to IgA.
Focal proliferative glomerulonephritis (FPGN) (Figs. 11
to 20). This group comprises patients with focal-segmental
proliferative or sclerotic glomerular lesions in whom
systemic disease or specific renal disease have been ruled
out (i.e., SLE, Henoch-Schönlein purpura, Goodpasture's
syndrome, focal embolic glomerulonephritis of bacterial
endocarditis, polyarteritis, etc.). Most of these cases,
characterized by proteinuria and mild or recurrent hema-
tuna, are idiopathic in origin and sume presumably
represent stages of resolution of previous, diffuse prolif-
erative glomerulonephritis.
Twelve of 21 renal biopsies (57%) with FPGN were
positive for IgA. Three of the 12 had generalized, diffuse
mesangial, 3+ granular deposits of IgA (Fig. 12); lgG was
segmentally localized in mesangial regions in two of these
biopsies, and was similar to IgA in the other. Six of the
12 had generalized segmental mesangial deposits of IgA and
IgG. 1gM was extremely variable and did not correlate
with either IgA or IgG in those nine biopsies. In the three
remaining biopsies, IgA along with IgG and 1gM was
located in globs within one to three lobular segments of
tufts, corresponding to the segmental proliferative glome-
rular lesions seen on light microscopy (Figs. 16—17).
Distribution of C3 and C4 was similiar to that of IgG
and 1gM.
Henoch-Schönlein purpura (HSP). Five of six patients
with clinically diagnosed HSP and associated FPGN on
renal biopsy had diffuse and generalized mesangial localiza-
tion of IgA. Four of these also had both IgG and 1gM with
C3, and one had IgG with C3 in similar distribution. The
one patient who was negative for IgA but who had both
IgG and 1gM was a 42-year-old male with an atypical
clinical presentation and a more chronic FPGN with
extensive glomerular sclerosis.
Focal sclerosing glomerulonep hr op at hy with segmental
hyalinosis (FSGN). This is a recently described, now clearly
recognizable renal disease [12, 13], clinically characterized
by nephrotic syndrome, usually with onset in young
persons, that is progressively complicated by hypertension
and renal failure. The glomerular lesion consists of focal-
segmental, nonproliferative capillary sclerosis and collapse
with locally prominent endocapillary foam cells and hyaline
insudate containing clear vacuoles.
Renal biopsies from six of 24 patients (25 %) with FSGN
were positive for IgA. In two biopsies IgA was diffuse 3 +
along with IgG and C3 within mesangial regions of all
glomeruli examined. 1gM was negative in one of these two
biopsies and only minimally present in the other. Two
other biopsies had segmental 2+ globs of igA, 1gM, lgG,
and C3 in capillary walls and mesangium of most glomeruli.
The remaining two biopsies had IgA, 1gM, IgG, and C3 in
some glomeruli only in a segmental portion of peripheral
capillary walls, but not within mesangial regions.
Minimal-change glomerulonephropathy (MCGN). This
disease, characterized by nephrotic syndrome of idiopathic
origin, commencing most often in young individuals and
usually responding satisfactorily to steroid therapy, has
very little in the way of glomerular alterations recognizable
by light microscopy, hence the designation minimal-change
glomerulonephropathy, light negative or "nil-disease." The
glomeruli are usually immunofluorescence negative, and
ultrastructurally, there is intermittent, often extensive, loss
of epithelial foot processes, hence the alternative designa-
tion "foot-process disease."
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Twenty-two patients were considered by clinicopatho-
logic criteria to have MCGN with nephrotic syndrome and
these were totally negative for deposits of any immuno-
globulins or C3.
Figs. 11 to 15. Focal proliferative glomerulonephritis, with diffuse
mesangial glomerular localization of immunoglobulins, C3, and
C4 by immunofluorescence microscopy. Fig. 11, H &E (x 245);
Fig. 12, IgA(x 240); Fig. 13, IgM(x 230); Fig. 14, C3 (x 170);
Fig. 15, C4 (x 240).
Minimal glo,nerular changes with indeterminable diagnosis.
Patients included in this group comprise those that ap-
parently do not have idiopathic nephrotic syndrome with
minimal-change glomerulonephropathy described above
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Figs. 16 to 20. Focal proliferative glomerulonephritis with segmental sclerosis, with focal, segmental, mesangial and peripheral gb-
merular localization of immunogbobulins and C3 by immunofluorescence microscopy. Fig. 16, H & E (x 260); Fig. 17, IgA (X 180);
Fig. 18, IgG, 2 glomeruli (x 160); Fig. 19, 1gM, 2 glomeruli (x 170); Fig. 20, C3 (x 230).
Fig. 21. Malignant arteriolonephrosclerosis showing IgA within the wall of an arteriole, mesangium and capillary walls of a gbomerulus,
and tubular cast. Immunofluorescence microscopy (x 180).
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and do not have sufficient glomerular alterations to be
labeled as stalk or focal proliferative glomerulonephritis.
These patients consitute a diagnostic problem and are
included in this category because they cannot be placed in
the other better defined clinical and pathologic categories
included in this study. As in stalk glomerulonephritis, some
biopsies in this category may represent examples either of
insufficient biopsy sample, which missed a focal glomerular
lesion, or of early disease yet to progress to a clinical and
pathologic stage with accumulation of sufficiently diagnostic
features.
Fifty-eight patients in this category had recurrent micro-
scopic hematuria, nephrotic syndrome, or minimal persist-
ent proteinuria with minimal glomerular changes, often
indistinguishable by light microscopy from "light-negative
disease." Some minimal glomerular changes were observed
in this group and consisted, at the maximum, of only
mildly increased numbers of mesangial cells with minimal
segmental increases of PAS positive mesangial membrane
matrix. Six patients had rare focal global glomerulosclerosis
without any segmental glomerular lesions. Twenty-three
(40%) had granular, predominantly mesangial, glomerular
deposits of igA and TgG. 1gM was also present in 14 of
these 23 patients, although in inconsistent, heterogenous
patterns. Deposits of C3 and C4 were distributed and
localized within the IgG/IgM positive regions.
Amyloidosis. Three of six patients with amyloidosis had
glomerular deposits of TgA along with lgG, 1gM, and C3
in segmental granular patterns in mesangium and capillary
walls.
Wegener's granulomatosis. One of four patients with
Wegener's granulomatosi s had glomerular localization of
IgA, IgG, 1gM, and C3 in a limited segmental, granular
distribution along peripheral capillary walls of some gb-
meruli. Occasional arterioles were also positive for IgA,
1gM, IgG, and C3.
Malignant arteriolonephrosc!erosis (Ma! A JVS). Three of
17 patients with Mal ANS had IgA localization along with
IgG, 1gM, and C3 within the walls of small arterioles
(Fig. 21). Two of these three patients also had granular
IgA, segmentally along peripheral portions of capillary
walls in some glomeruli (Fig. 21).
Miscellaneous. Kidney biopsies from four patients with
diabetic glomerulosclerosis, three with chronic lobular
glomerulonephriis, and one with thrombotic thrombo-
cytopenic purpura were all negative for glomerular deposits
of igA.
Discussion
In a group of 470 kidney biopsies from patients with
various glomerulonephropathies, glomerular deposits of
IgA were observed in 159 (34%) biopsies. Among these 159
biopsies, IgA was associated with IgG, 1gM, and C3 in
83%, with 1gM and C3 in 7%, and with IgG and C3 in
9% and occurred alone in only 1 % of the biopsies. C4,
where studied, generally followed the patterns of IgG and/or
1gM. Glomerular deposition of IgA in five of six patients
with HSP is in accordance with similar observations
reported by others [1—5. The 60% incidence of IgA in
SLE is somewhat higher than that reported by others [1,
6—8]. IgA localization, though striking in SLE, was not
specifically diagnostic due to marked variability in patterns
of localization. In AGN, IgA was frequently observed
within mesangial regions, whereas complement-fixing
immunoglobulins as well as C3 were observed more
characteristically along peripheral capillary walls. The
incidence of IgA in MbPGN is in agreement with the
findings of others [17].
Within the past five years there have been several reports
[1—4] of a recently described entity: IgG-lgA glomerulo-
pathy. This diagnosis was made primarily on the findings
of IgG, IgA, and C3 deposits within glomerular mesangial
regions. 1gM was reported to be notably absent in most
cases. Histologic changes described on light microscopy
were variable, but the predominant lesion consisted of focal-
segmental, proliferative and sclerotic glomerular changes
with a background of minimal stalk changes or later of
advanced chronic sclerotic glomerular changes. In our
present series, 18 biopsies have immunofluorescence
findings superficially compatible with so-called IgA-TgG
nephropathy. By light microscopy one of these 18 biopsies
was interpreted as AGN, one as MbGN, and one as FSGN.
In addition, four of these biopsies were consistent with SLE
with predominantly mesangial TgA, IgG, and less 1gM
and C3. One positive biopsy was obtained from a patient
with HSP. If these cases with specific clinicopathologic
diagnoses are excluded from consideration, this leaves
ten patients as possibly having IgG-IgA glomerulopathy.
Nine were interpreted as having minimal glomerular
changes with indeterminable diagnosis and one as FPGN.
The maximum incidence of so-called IgA-IgG nephropathy
in our total series of 470 patients, therefore, would be 2.1 %,
significantly less than the 18% reported by Berger [1].
Whether IgA-IgG nephropathy can or should be singled
out as a distinct entity is questionable on the grounds that
immunofluorescence and light microscopic glomerular
alterations, as well as presumably etiologic and pathogenetic
mechanisms, are mimicked more frequently by a variety
of other well characterized glomerular diseases.
In light of this present study, deposition of IgA apparently
is not diagnostically specific as indicated by the hetero-
geneous variety of glomerulopathies, patterns, and in-
cidence of companion globulins with which it is observed.
Moreover, demonstration of gbomerular deposition of
IgA, though sometimes helpful, is basically of little practical
value in the differential diagnosis of similar appearing
glomerular lesions. For example, the presence and distribu-
tion of IgA may be similar in focal, segmental, or prolif-
erative glomerular lesions of SLE, HSP, and FPGN, and
in some examples of minimal glomerular alterations or
SPGN. However, comparative identification and charac-
terization of IgA deposition with other immunoglobulins
IgA in glomerular diseases 407
may be of some diagnostic value. Therefore, it appears
more logical to continue using a system of diagnostic
nomenclature based on combined clinical and histo-
pathologic findings, and to use IgA positivity along with
the presence or absense of other immunoglobulins in an
attempt to further elucidate possible immunologic mecha-
nisms in the pathogenesis of glomerulonephropathies.
The immunopathologic role of IgA in renal glomerular
disease is unclear. Seldom does IgA appear as the only
localized immunoglobulin in diseased glomeruli, and there-
fore, if localized complement-fixing immunoglobulins (IgG
and 1gM) do play a pathogenetic role in certain glomerulo-
nephropathies (and considerable evidence favors this), then
it is difficult to implicate IgA itself as a single or major
cause of glomerular lesions. A recent report indicating
that aggregated IgA may initiate complement activity at
the C3 reaction step [181 suggests a possible synergistic
pathogenetic contribution by deposits of IgA. However, it
was quite apparent in this study that patterns of localized
host C3 (and parenthetically in vitro fixation of guinea pig
C3 and C4) parallel more closely those pattelns of IgG
and/or 1gM rather than IgA. Furthermore, since IgA is
most often found with other immunoglobulins in glomeruli
in a wide variety of glomerular lesions and disease processes,
it is difficult to ascribe any primary pathogenetic mecha-
nism or specific significance to IgA localization.
Very little is known about mediator mechanisms asso-
ciated with IgA complexes or about immunologic activity
of IgA in regions other than mucosal surfaces, and so it is
difficult to assess the consequences of IgA localization in
glomeruli. In selected cases of HSP, high levels of circu-
latory IgA have been identified and have led to speculation
of a possible IgA-mediated hypersensitivity or immune-
complex phenomenon related to predominant IgA immune
response in respiratory or gastrointestinal microbial infec-
tions or allergies [19]. In a few cases of lupus erythematosus,
antinuclear antibodies of the IgA class have been identified,
and it therefore is possible that selected individuals might
localize IgA antinuclear complexes in glomeruli during
development of SLE nephropathy [20]. Also the rare
occurrence of rheumatoid factors of the IgA class might
on occasion account for localization of IgA antiglobulin at
glomerular sites of previously bound IgG or 1gM immuno-
globulins [211. The common mesangial location of IgA
may, on the one hand, reflect preferential phagocytosis of
IgA complexes by mesangial cells, or on the other hand,
possible migration from capillary walls of noncomplement
fixing IgA complexes which, in contrast to complement-
fixing immune aggregates, might be less likely to remain
bound in peripheral portions of glomerular capillary walls.
An unlikely, but tantalizing explanation for the pre-
dominant mesangial localization of IgA is possible local
synthesis and secretion of IgA by mesangial cells in selected
glomerular injuries. Whether the glomerular bound IgA is
of the circulating or secretory class of IgA is not yet clear,
but results of preliminary studies would suggest that
secretory IgA may be present in deposits since secretory
piece has been identified with specific antisecretory piece
antibody in the same location as IgA in a few cases [Hyman,
L. R., Burkholder, P.M., Zimmerman, S., and Hong, R.,
unpublished observations].
If IgA is deposited in glomeruli in immune aggregates,
then the nature of the possible antigens involved is un-
known. TgA antibodies reactive with diphtheria [22],
coliform, or other common bacteria, viruses (commonly
enteric or respiratory) [23] or nuclear antigens [20] have
been identified and could be responsible for immune-
complex deposition in glomerular capillaries in selected
circumstances. Of possible correlative significance is
exacerbation of symptoms of renal disease in MbPGN,
SLE nephritis, minimal glomerular changes, FPGN, or
HSP in apparent association with upper respiratory
infections of viral or other microbial etiology. Even though
presence of IgA in glomerular lesions is not clearly di-
agnostically specific, and the nature and significance of
localized IgA are not understood, it is hoped that continued
assessment for the presence and possible participation of
IgA in glomerulonephropathies will provide new clues.
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